Caisse de depot et placement du Quebec
Position in MEDP — Medpace Holdings, Inc.
CIK 898286
Montreal, A8
Position in MEDP
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$62,544,267
+$17,489,828 QoQ
Shares Held
130,249
+62.4% QoQ
Ownership
0.456%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MEDP Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Caisse de depot et placement du Quebec holds $594,399,285 across 13 Diagnostics & Research names. MEDP ranks #5 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
263,051 | $147,805,726 | |
| 2 | DHR |
Danaher Corp /De/
|
508,798 | $96,468,100 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
60,007 | $75,680,828 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
144,811 | $71,178,950 | |
| 5 | MEDP |
Medpace Holdings, Inc.
This page
|
130,249 | $62,544,267 | |
| 6 | QGEN |
Qiagen N.V.
|
1,415,876 | $56,691,675 | |
| 7 | ILMN |
Illumina, Inc.
|
431,767 | $53,219,600 | |
| 8 | WAT |
Waters Corp /De/
|
57,648 | $17,167,574 |
All Filings in MEDP
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $62,544,267 | 130,249 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $45,054,439 | 80,218 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $33,545,340 | 65,243 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $63,548,489 | 202,474 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $70,238,357 | 230,524 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $57,997,058 | 174,569 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $23,320,603 | 69,864 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||